Little is known about the natural history of non-significant mitral and tricuspid regurgitation (MR and TR) following surgical aortic valve replacement (SAVR) for aortic regurgitation (AR). We retrospectively analyzed 184 patients (median age 64 (IQR, 55–74) years, 76.6% males) who underwent SAVR for AR. Subjects with significant non-aortic valvulopathies, prior/concomitant valvular interventions, or congenital heart disease were excluded. The cohort was evaluated for MR/TR progression and, based on the latter’s occurrence, for echocardiographic and clinical indices of heart failure and mortality. By 5.8 (IQR, 2.8–11.0) years post-intervention, moderate or severe MR occurred in 20 (10.9%) patients, moderate or severe TR in 25 (13.5%), and either of the two in 36 (19.6%). Patients who developed moderate or severe MR/TR displayed greater biventricular disfunction and functional limitation and were less likely to be alive at 7.0 (IQR, 3.4–12.1) years compared to those who did not (47.2 vs. 79.7%, p < 0.001). The emergence of significant MR/TR was associated with preoperative atrial fibrillation/flutter, symptomatic heart failure, and above-mild MR/TR as well as concomitant composite graft use, but not with baseline echocardiographic measures of biventricular function and dimensions, aortic valve morphology, or procedural aspects. In conclusion, among patients undergoing SAVR for AR, significant MR/TR developed in one fifth by six years, correlated with more adverse course, and was anticipated by baseline clinical and echocardiographic variables.
This case series highlights the unique presentation and diagnostic challenges of coronary artery disease (CAD) in female athletes. Despite generally lower prevalence, women may experience atypical symptoms and delays in diagnosis, often due to the under-recognition of risk and subtle clinical signs. We describe 3 cases of CAD among women during different stages of life: a postmenopausal long-distance runner with complex coronary anatomy, a postmenopausal triathlete with severe left anterior descending artery stenosis, and a young climber in her reproductive years with acute coronary syndrome. These cases underscore the importance of thorough evaluation, including advanced imaging such as coronary computed tomography angiography, and reveal how gender-specific factors, menopause, and training patterns influence CAD detection and outcomes. There is a need for tailored, athlete-specific diagnostic algorithms to ensure early identification and management of CAD in women, ultimately reducing gender disparities in cardiovascular care and improving prognosis in female athletes.
A 17-year-old athlete was initially diagnosed with presumed hypertrophic cardiomyopathy, marked by deep inferolateral T-wave inversions and mild anteroseptal hypertrophy on electrocardiogram and imaging studies. Remarkably, 6 years later, following detraining, all diagnostic signs completely resolved. This case underscores the significance of vigilant athlete follow-up.